An economic assessment of the extent of medication use and wastage among families in Saudi Arabia and Arabian Gulf countries
An economic assessment of the extent of medication use and wastage among families in Saudi Arabia and Arabian Gulf countries
复制标题
DOI：
10.1016/s0149-2918(03)80083-8
复制
发表时间：
2003-04-01
影响因子：
3.2
通讯作者：
Abou-Auda, HS
中科院分区：
文献类型：
--
作者：
Abou-Auda, HS
背景：处方药和非处方药的支出占医疗保健总成本的很大比例。政府、医疗服务提供者和消费者必须共同努力，找到控制这些成本的方法，同时继续为他们的国家提供高质量的医疗服务。为此，药物浪费是一个不必要的负担，对一个已经受到限制的卫生保健system.Objective：本研究进行了确定的程度，在阿拉伯海湾国家的家庭之间的药物使用和浪费，重点是沙特阿拉伯。方法：问卷调查，并管理在沙特阿拉伯和其他海湾国家的5个地区的家庭。共有1641户家庭参与了这项研究（沙特阿拉伯1554人;其他国家87人）。来自沙特阿拉伯的家庭受访者的平均家庭规模为6.60（3.20）名成员，0.32%的家庭报告家中没有药品，81.8%的家庭报告有5种或5种以上药品，29.9%的受访者报告家中至少有10种药物。总体而言，沙特阿拉伯每个家庭的平均（SD）药物数量为8.0（43）。在沙特阿拉伯，最常见的治疗类药物是呼吸系统药物（16.8%）、中枢神经系统药物（16.4%）和抗生素（14.3%）。在沙特阿拉伯和其他海湾国家，未使用、变质或过期药品的平均（SD）数量分别为每户2.2（2.7）和2.7（1.9）。根据这些数据，平均药物浪费估计为25.8%（沙特阿拉伯）和41.3%（其他海湾国家）。当根据总药物费用进行分析时，沙特阿拉伯和其他海湾国家的药物浪费分别为19.2%和25.0%。（根据年收入的百分比）沙特阿拉伯家庭的药物支出为0.72%，而其他海湾国家为0.48%。沙特阿拉伯和其他海湾国家的家庭总共花费了图斯1.5亿美元购买从未服用过的药物。然而，似乎没有立即解决药物浪费对医疗保健费用的影响问题的办法。应促进使用非专利替代品，并应在国家一级进行药物使用评估。版权所有（C）2003 Excerpta Medica，Inc.
Background: Expenditures for prescription and over-the-counter medications constitute a large percentage of total health care costs. Governments, health care providers, and consumers must work together to find ways to control these costs while continuing to provide quality health care for their nations. To this end, medication wastage is an unnecessary burden on an already fiscally restrained health care system.Objective: This study was conducted to identify the extent of medication use and wastage among families in the Arabian Gulf countries, with an emphasis on Saudi Arabia.Methods: A questionnaire was developed and administered to households in 5 regions in Saudi Arabia and other Gulf countries. A total of 1641 households participated in the study (1554 in Saudi Arabia; 87 in other countries).Results: The mean (SD) family size of household respondents from Saudi Arabia was 6.60 (3.20) members, with 0.32% reporting no medicines present in the household, 81.8% of households reporting 5 or more medicines, and 29.9% of respondents reporting having at least 10 medications at home. Overall, the mean (SD) number of medicines per household in Saudi Arabia was 8.0 (43). The most common therapeutic classes of medications kept at home in Saudi Arabia were respiratory medications (16.8%), central nervous system agents (16.4%), and antibiotics (14.3%). The mean (SD) number of drug products unused, deteriorated, or expired was 2.2 (2.7) and 2.7 (1.9) per household in Saudi Arabia and other Gulf countries, respectively. From these data, mean medication wastage was estimated to be 25.8% (Saudi Arabia) and 41.3% (other Gulf countries). When analyzed on the basis of total medication cost, medication wastage was 19.2% and 25.0% in Saudi Arabia and other Gulf countries, respectively The mean out-of-pocket expenditure (based on the percentage of annual income) for medications was 0.72% for households in Saudi Arabia compared with 0.48% in other Gulf countries.Conclusions: Families in Saudi Arabia and other Gulf countries spent a total of similar toUS $150 million on medications that were never consumed. However, there appear to be no immediate solutions to the problem of medication wastage's impact on health care costs. The use of generic alternatives should be promoted, and drug use assessments should be implemented on a national level. Copyright (C) 2003 Excerpta Medica, Inc.